T-cell epitope determination.
暂无分享,去创建一个
[1] F. Sinigaglia,et al. Promiscuous and allele-specific anchors in HLA-DR-binding peptides , 1993, Cell.
[2] T. Ruppert,et al. Elongated peptides, not the predicted nonapeptide stimulate a major histocompatibility complex class I‐restricted cytotoxic T lymphocyte clone with specificity for a bacterial heat shock protein , 1994, European journal of immunology.
[3] K. Parker,et al. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.
[4] K. Wiesmüller,et al. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. , 1994, Journal of immunological methods.
[5] G Hermanson,et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. , 1995, Journal of immunology.
[6] J. Berzofsky,et al. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. , 1995, Vaccine.
[7] T. Meyer,et al. Requirements for Peptide Binding to the Human Transporter Associated with Antigen Processing Revealed by Peptide Scans and Complex Peptide Libraries (*) , 1995, The Journal of Biological Chemistry.
[8] J. Drijfhout,et al. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. , 1995, Human immunology.
[9] J. Abastado,et al. Systematic identification of H-2 Kd binding peptides and induction of peptide specific CTL. , 1994, Journal of immunological methods.
[10] S. Stacey,et al. Identification of a naturally processed HLA A0201‐restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein , 1994, European journal of immunology.
[11] K Eichmann,et al. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. , 1995, Immunity.
[12] R. Henderson,et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. , 1994, Science.
[13] D. Madden. The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.
[14] Andrew Brooks,et al. Peptide binding to MHC class I molecules: Implications for antigenic peptide prediction , 1995, Immunologic research.
[15] P. A. Peterson,et al. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.
[16] R. Houghten,et al. The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands. , 1993, Life sciences.
[17] S. Kienle,et al. Decrypting the structure of major histocompatibility complex class I- restricted cytotoxic T lymphocyte epitopes with complex peptide libraries , 1995, The Journal of experimental medicine.
[18] M. Bevan,et al. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. , 1993, Journal of immunology.
[19] K. Vousden,et al. Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein. , 1994, International immunology.
[20] K. Wiesmüller,et al. Elucidation of T-cell epitopes: a synthetic approach with random peptide libraries. , 1995, Biochemical Society transactions.
[21] Stefan Kienle,et al. Tolerance to Amino Acid Variations in Peptides Binding to the Major Histocompatibility Complex Class I Protein H-2Kb(*) , 1995, The Journal of Biological Chemistry.
[22] S. Tonegawa,et al. Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator , 1994, The Journal of experimental medicine.
[23] H. Eisen,et al. A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Kienle,et al. Determination of T cell epitopes with random peptide libraries. , 1996, Journal of immunological methods.
[25] H. Rammensee,et al. Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA‐A2.1 , 1994, International journal of cancer.
[26] P. Parham,et al. Peptide binding to major histocompatibility complex molecules. , 1993, Annual review of cell biology.
[27] R. Germain,et al. The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.
[28] A. Sette,et al. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. , 1995, Journal of immunology.
[29] T. Hogg,et al. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. , 1994, International immunology.
[30] J. Sidney,et al. Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles. , 1994, Molecular immunology.
[31] J. Sidney,et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.
[32] T. Ottenhoff,et al. Mapping of multiple HLA class II-restricted T-cell epitopes of the mycobacterial 70-kilodalton heat shock protein , 1994, Infection and immunity.
[33] M. Feltkamp,et al. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. , 1994, Molecular immunology.
[34] Z. Nagy,et al. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.
[35] J. Reimann,et al. Peptide transporter‐independent, stress protein‐mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation , 1994, European journal of immunology.
[36] P. Parham,et al. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes , 1995, Current Biology.
[37] M F del Guercio,et al. Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.
[38] H. Grey,et al. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. , 1995, Journal of immunology.
[39] P. Romero,et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes , 1994, The Journal of experimental medicine.
[40] H. Eisen,et al. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein , 1992, Cell.
[41] A. Worth,et al. Characterization of two Epstein‐Barr virus epitopes restricted by HLA‐B7 , 1995, European journal of immunology.
[42] Peter Walden,et al. Exact prediction of a natural T cell epitope , 1991, European journal of immunology.
[43] V. Engelhard,et al. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice. , 1995, International immunology.
[44] R. Henderson,et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.
[45] B. Seliger,et al. Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes , 1994, European journal of immunology.
[46] A. Vitiello,et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.
[47] M. Eisenstein,et al. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma , 1994, Nature.
[48] F. Sinigaglia,et al. Motifs and supermotifs for MHC class II binding peptides , 1995, The Journal of experimental medicine.
[49] P. Coulie,et al. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Oldstone,et al. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes , 1995, Journal of virology.
[51] V. Gnau,et al. Analysis of a naturally occurring HLA class I-restricted viral epitope. , 1994, Immunology.
[52] D. Margulies,et al. Determinant selection of major histocompatibility complex class I- restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues , 1994, The Journal of experimental medicine.
[53] M. Bevan,et al. Major histocompatibility complex class I allele‐specific peptide libraries: Identification of peptides that mimic an H‐Y T cell epitope , 1994, European journal of immunology.
[54] A. Agulnik,et al. Identification of a mouse male-specific transplantation antigen, H-Y , 1995, Nature.
[55] A. Agulnik,et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. , 1995, Science.
[56] J. Neefjes,et al. Peptide size selection by the major histocompatibility complex-encoded peptide transporter , 1994, The Journal of experimental medicine.